This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

XCHC Invites Shareholders And Stakeholders To Amplify The February 25 Lobby Day Efforts Of The Americans For Safe Access Unity Conference, Act By Contacting Your State And Federal Elected Officials

DALLAS, Feb. 26, 2013 /PRNewswire/ -- X-Change Corp. (NASDAQ OTC: XCHC), a patient based U.S. company targeting critical and non-critical ailments through the use of Cannabinoid based formulations, extracts, and products through multiple Phytiva Brand product lines and solutions, strongly encourages like-minded citizens to contact their elected officials in support of safe access to cannabinoids for medical use in conjunction with the "lobby day" efforts of the Americans for Safe Access (ASA) National Medical Cannabis Unity Conference 2013 held in Washington, D.C. during the last four days.

Consistent with the findings and discussions at the ASA conference, the Company has already publicly launched two initiatives in this area with its Phytiva Brand European Cannabinoid product line and its Cannabinoid treatment-based facility development agreement with the Maliseet Nation in Eastern Canada. 

"As an ASA conference participant, it is clear that the time is now to persuade our regulatory authorities of the proven efficacy of cannabinoid based medicine, products, and treatments.  These therapies are already being utilized in the U.S. and around the world in a successful, rigorous, and professional manner.  It is in the interest of human healthcare to support these cannabinoid efforts and to place an even greater emphasis on increasing research into the healing properties of cannabinoids," stated Chad S. Johnson, Chief Operating Officer and General Counsel of X-Change Corp.

The ASA conference successfully brought together medical cannabinoid patients and supportive medical professionals, scientists, attorneys, policy experts, politicians, and other stakeholders in the medical cannabinoid space to create an environment for enhancing and expanding safe access to life-saving medicines and treatments.  With the positively shifting ground around medical cannabinoids, this conference located in the nation's capital, continued to move the U.S. down the rational path of cannabinoid acceptance and use.  More information about the mission, agenda and participants of the ASA conference is available at http://safeaccessnow.org/blog/conference2013/.  With more than eighty percent (80%) of Americans in favor of cannabinoid medicine, the Company is well positioned as a corporation and as a socially responsible entity to continue the Company's leadership in this burgeoning international industry.

About Phytiva Brand Product Lines

1 of 3

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 16,943.81 +28.74 0.17%
S&P 500 1,967.57 +2.89 0.15%
NASDAQ 4,415.49 +19.2860 0.44%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto
Advertising Partners

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs